Assyro AI

FDA Orange Book · active-ingredient family

Nitrofurantoin; nitrofurantoin, macrocrystalline

Nitrofurantoin; nitrofurantoin, macrocrystalline is approved as 1 brand and 12 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:MACROBID · NDA 020064

1

Brand (NDA)

12

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · capsule

ProductApplicantApplicationTEApproved
MACROBIDRLDALMATICANDA 020064ABDec 24, 1991

Generic (ANDA) products (12)

ProductApplicantApplicationTEApproved
NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS)CREEKWOOD PHARMSANDA 220269ABApr 07, 2026
NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS)OMSAV PHARMAANDA 217073ABNov 03, 2023
NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS)MANKIND PHARMAANDA 217357ABJul 11, 2023
NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS)AUROBINDO PHARMAANDA 209225ABMar 30, 2023
NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS)ALVOGENANDA 215002Jul 20, 2022
NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS)INVENTIAANDA 211013ABFeb 18, 2022
NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS)SUNNYANDA 208516ABMay 24, 2018
NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS)AMNEAL PHARMSANDA 207372May 15, 2017
NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS)WATSON LABS INCANDA 202250ABJul 08, 2015
NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS)SANDOZANDA 077066ABApr 05, 2005
NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS)RANBAXY LABS LTDANDA 076951Mar 30, 2005
NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS)CHARTWELL RXANDA 076648Mar 22, 2004

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Nitrofurantoin; nitrofurantoin, macrocrystalline — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.